Proglumetacin
Clinical data | |
---|---|
Other names | 3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Pharmacokinetic data | |
Metabolism | Hepatic. Undergoes enterohepatic recirculation |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C46H58ClN5O8 |
Molar mass | 844.45 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Proglumetacin (usually as the maleate salt, trade names Afloxan, Protaxon and Proxil) is a nonsteroidal anti-inflammatory drug (NSAID). It is metabolized in the body to indometacin and proglumide,[1] a drug with antisecretory effects that helps prevent injury to the stomach lining.
References
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.